Atormac
briv
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 3452  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 Search
 
  
 Resource Links
  »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
  »  Article in PDF (1,667 KB)
  »  Citation Manager
  »  Access Statistics
  »  Reader Comments
  »  Email Alert *
  »  Add to My List *
* Registration required (free)  

 
  In this Article
 »  Abstract
 »  Materials and Me...
 » Results
 » Discussion
 » Conclusion
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed456    
    Printed0    
    Emailed0    
    PDF Downloaded29    
    Comments [Add]    

Recommend this journal

 


 
Table of Contents    
ORIGINAL ARTICLE
Year : 2021  |  Volume : 69  |  Issue : 1  |  Page : 49-55

A 270-Degree Decompression of Optic Nerve in Refractory Idiopathic Intracranial Hypertension Using an Ultrasonic Aspirator - A Prospective Institutional Study


Department of Neurosurgery, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Telangana State, India

Date of Submission19-Mar-2020
Date of Decision09-Sep-2020
Date of Acceptance03-Oct-2020
Date of Web Publication24-Feb-2021

Correspondence Address:
Rajesh Alugolu
Department of Neurosurgery, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad - 500082, Telangana State
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0028-3886.310080

Rights and Permissions

 » Abstract 


Background: Although the nonsurgical treatment for idiopathic intracranial hypertension (IIH) involves weight loss, diuretics, and steroids, surgical intervention is required if there is a worsening of symptoms or visual deterioration.
Objective: To determine the efficacy and complications of transcranial optic nerve sheath fenestration (ONSF) using an ultrasonic aspirator as an adjunct in the treatment of refractory IIH.
Material and Methods: This prospective study included all patients with medically refractory IIH with visual deterioration from November 2017 to June 2019. Pterional craniotomy was followed by extradural clinoidectomy and optic foramen bony decompression using an ultrasonic aspirator. All the cases were followed up for changes in visual acuity and field and surgical outcomes.
Results: A total of 21 consecutive patients who underwent ONSF in the study period were included for analysis. Improvement in visual acuity was noted in 19/21 (90.47%) patients. Improvement in visual fields was noted in 17/21 (80.95%). Headache improved in 66.67% of patients. Improvement in the fundus picture was noted in 90.47%. Symptoms < 6 months showed better results compared to > 6 months symptom, although statistically nonsignificant (P = 0.2556). A 270-degree optic canal decompression was achieved in all the cases.
Conclusion: Transcranial optic nerve sheath decompression with a bone ultrasonic aspirator is a safe and direct decompression of the optic nerve in malignant/refractory cases of IIH.


Keywords: IIH, modified Dandy's criteria, ONSF, visual acuity, visual fields
Key Message: Direct and maximal decompression of the optic nerve is useful not only in saving vision on one side but improves vision on contralateral side as well.


How to cite this article:
Wadikhaye R, Alugolu R, Mudumba VS. A 270-Degree Decompression of Optic Nerve in Refractory Idiopathic Intracranial Hypertension Using an Ultrasonic Aspirator - A Prospective Institutional Study. Neurol India 2021;69:49-55

How to cite this URL:
Wadikhaye R, Alugolu R, Mudumba VS. A 270-Degree Decompression of Optic Nerve in Refractory Idiopathic Intracranial Hypertension Using an Ultrasonic Aspirator - A Prospective Institutional Study. Neurol India [serial online] 2021 [cited 2021 Apr 10];69:49-55. Available from: https://www.neurologyindia.com/text.asp?2021/69/1/49/310080




Idiopathic intracranial hypertension (IIH), is a disorder of unknown cause presenting with increased intracranial pressure (ICP) and the symptoms associated resulting from defective cerebrospinal fluid (CSF) absorption[1] and is typically seen in obese women of childbearing age, with a worldwide incidence of 12–20 per 100000 people per year in this group,[2] while its incidence in the general population is 0·5–2 per 100 000 people per year.[3] IIH is diagnosed by using modified Dandy criteria,[4] which includes: (1) signs and symptoms due to raised ICP, (2) other than unilateral or bilateral lateral rectus palsy, no other neurological signs are seen, (3) increased CSF opening pressure (≥25 cm of water) with normal CSF analysis, and (4) no abnormality on brain imaging. Patients with malignant IIH present with the following symptoms: (i) rapid onset of the disease, (ii) severe visual loss with a duration of <4 weeks after the onset of disease, and (iii) a recent rapid worsening of visual symptoms.[5] Nonsurgical management includes weight loss, diuretics, steroids, and multiple lumbar punctures.[1] Surgery in the form of either optic nerve sheath decompression (ONSD) or CSF diversion procedure is indicated in case of failure to respond to medical management.[6] Optic nerve decompression was earlier performed through the transconjunctival route. The success in visual improvement was associated with high rates of complications which included diplopia, anisocoria, orbital apex syndrome, traumatic optic neuropathy, and orbital hematoma.[7] The endoscopic approach for optic nerve decompression had complications of CSF leak, cavernous sinus hemorrhage, epistaxis, and the degree of optic canal decompression was inadequate. A cadaveric study by Gogela et al. demonstrated a significantly higher degree of optic canal decompression through a transcranial approach as compared to the endonasal approach.[8] Injury to carotids/visual apparatus limits the full potential of such surgeries.[9],[10] Recently, the use of an ultrasonic bone aspirator for clinoidectomy is safe, requiring less expertise than the standard drilling.[11] There is a lack of evidence-based studies highlighting the risk and benefits of different surgical methods over one another,[12] which was also confirmed by a recent Cochrane collaboration.[13]

To determine the efficacy and extent of bony decompression of optic canal in ONSF using ultrasonic aspirator as an adjunct in the management of medically refractory IIH.


 » Materials and Methods Top


This prospective study was carried out in the Department of Neurosurgery, Nizam's Institute of Medical Sciences, Hyderabad, India from November 2017 to June 2019. The study protocol was approved by the Institutional Ethical Board.

Inclusion criteria

All patients of IIH (diagnosed using modified Dandy criteria) were referred to the neurosurgery following failed medical management and a recent onset visual deterioration (≥2 lines on Snellen's chart) was included in the study.

Exclusion criteria

Patients who 1) responded to medical management, 2) patients who did not consent for surgery, and 3) those lost to follow-up before evaluation in the postoperative period.

A detailed history was elicited to exclude any medical disorder or drug usage as an etiologic factor for IIH. The neurological examination included visual acuity, perimetry, and fundoscopy. Magnetic resonance imaging (MRI) along with magnetic resonance venography (MRV) of the brain was performed to rule out the secondary cause of IIH. CSF opening pressures were measured along with biochemical analysis. The study also included four patients who continued to have visual deterioration despite undergoing a CSF diversion procedure.

Basis of surgery

The cisternal spaces are all in communication with each other and not just exchange the CSF across but the pressure as well which is manifested distantly in the closed cranial cavity in raised ICP as in IIH, wherein the absorption is defective. The principle goal is to create an alternative CSF pathway, thus reducing the ICP and its effects.

Surgical procedure

Following a fronto-temporo-sphenoidotomy with head in mild hyperextension and neutral rotation, extradural clinoidectomy was performed after separating the cavernous sinus dura with a sharp dissector followed by ultrasonic aspirator (SONOCA 300/Soring, Germany) under high magnification as a standard clinoidectomy described by Dolenc. The decompression was extended over the foraminal roof superiorly till the medial margin of the foramen visible and then the bony decompression was continued along the optic strut till the sphenoid making the optic nerve free on superior, medial, and inferior aspect. The medial part of the sphenoid which is not accessible was left undisturbed. This when measured in the postoperative computed tomography (CT) scans measured 270-degrees freedoms for the optic nerve. The dura over the optic nerve was opened sharply along the length of the optic nerve followed by the opening of cisterns around the optic nerve to release CSF. The dural opening thus made was not sealed and along with the bone so drilled, created a pathway for egress of CSF, and a fistula so created was left to be communicating with the overlying muscle and subgalea for systemic absorption. [Figure 1], [See Video 1]
Figure 1: Intraoperative ACP removal using ultrasonic aspirator (a); postop CT scans images showing a 270-degree optic canal decompression (b, c, d – white arrow); (e) opposite nonoperated side

Click here to view


Follow-up

Headache was assessed by visual analog scale (VAS) scoring. Neuro-ophthalmological evaluation in the follow-up was done at 1 month, 3 months, and 6 months. Visual acuity was the primary outcome modality. Improvement in visual acuity was defined as a change of at least one line on the Snellen's chart. Improvement in visual fields was not quantified and was defined as contraction of field defect noted on a grayscale representation in Humphrey's visual field analyzer chart. Statistics were analyzed using statistical package for the social sciences (SPSS) 17.0 software (SPSS Inc., Chicago, IL). Univariate analysis using the Chi-square test and Fisher's exact test was performed to compare the postoperative visual improvement rate among different groups. Results were considered significant at P < 0.05.


 » Results Top


Demography

There were a total of 21 patients who met the defined criteria and were included in the study after being diagnosed to have IIH based on modified Dandy criteria. There were two males and 19 females (M: F = 1:9.5). The mean age of the study population was 27.47 years (range 16–44 years). The mean BMI was 26.80 (range 19.4–35.4 kg/m2).

Symptoms

The presenting complaints were recent-onset visual disturbance (n = 21, 100%), headache (n = 18, 85.71%), diplopia (n = 8, 38.09%), and pulsatile tinnitus (n = 4, 19.04%). Papilloedema of Frisen's grade = III was observed in 19 patients (90.47%).[14] Active symptoms of headache for more than 6 months were recorded in 14 patients (66.67%) while four patients had a duration of less than 6 months. The mean CSF opening pressure was 38.9 cm H2O (range 30–48 cm H2O). About four patients had theco-peritoneal (TP) shunt placement done before ONSF [Table 1]a.


Click here to view


Outcome

A significant improvement in vision described as best-corrected visual acuity (BCVA) was noted in (78.51%) 31 of 39 eyes (three eyes had 6/6 vision), more so on the side of surgery (19 of 21, 90.47%) [Table 1]b. Improvement in visual fields measured as improvement in contraction in the visual field defects was noted in 17 patients (80.95%) over the follow-up period [Figure 3]. Headache improved in 12 out of 18 patients (66.67%) [Table 2]. Complications included surgical site infection which required reexploration of the wound for debridement in one patient while another patient with prior TP shunt, developed subdural hygroma. The peritoneal end of the TP shunt had to be tied for symptom relief [Table 3]. When the improvement in visual outcome was compared between the group of patients with symptom less than 6 months (seven patients, 100% improvement) and those more than 6 months (14 patients, 71.42% improvement), no statistically significant difference was found (P = 0.2550). Besides, relief of headache in a patient undergoing ONSF as primary intervention (8 of 13, 61.54%) against those undergoing ONSF as secondary intervention (4 of 5, 80%) did not show any statistical significance (P = 0.6148). Papilloedema improved in all except two patients who had Frisen's grade V edema [Figure 2]. None of the patients had deterioration of the vision after the ONSF and patients who did not improve had stable vision until the last maximum follow-up period.
Table 2: Comparison of visual outcome in previous major studies

Click here to view
Table 3: Complications in different approaches of ONSF

Click here to view
Figure 2: Preop and postop fundus picture

Click here to view
Figure 3: Preop and postop visual fields

Click here to view



 » Discussion Top


Optic nerve sheath fenestration was first described in 1872 by DeWecker.[23] However, the use of ONSF for the treatment of IIH was first described by Hayreh in 1964.[24] The pathophysiologic mechanisms by which ONSF improves visual function are still debated. The suggested mechanisms include 1) fibroblast proliferation around the optic nerve causing obliteration of subarachnoid spaces, preventing transmission of raised ICP distal to the operative site[25] and 2) uninterrupted outflow of CSF from the dural fistula formed at the operative site.[26] Relief of headache due to a generalized decrease in ICP and bilateral improvement in visual function after surgery support this hypothesis.[27]

The decision for treatment of IIH depends upon the severity of IIH-related visual loss and headache. Patients who fail conservative measures (weight loss) and maximal medical therapy for lowering raised ICP and headache might benefit from surgical intervention.[28] A “frank visual loss” at presentation suggests a poor visual prognosis and is an indication for surgical intervention rather than weeks of medical management which takes long to assess its response.[15] The diminution of visual acuity in IIH indicates 1) involvement of macula by edema or 2) setting in of optic atrophy. ONSF is often the preferred surgical option in patients with predominant acute onset visual loss,[29] although headache has been found to improve in up to 50% cases.[30]

The approach for ONSF can be either transconjunctival, endoscopic endonasal, or transcranial. ONSF, through the medial transconjunctival approach the improvement of visual acuity was seen in 67–94% while visual field improvement was observed in 64–88%. The fundus picture improved in the range of 71–95%.[17],[16],[31],[18]

ONSF through the endoscopic approach in patients with IIH had improvement in visual field deficits up to 93.8%, visual acuity up to 85.3%, papilloedema up to 81.4%, and headaches up to 81.8%.[19]

Patients who underwent unilateral ONSF had improvement in visual function in nonoperated eye as well.[32] Our study had a 66.67% improvement in acuity and a 50% improvement in visual fields in the nonoperated eye. This was hypothesized to be due to decreased mean intrasheath CSF pressures of both optic nerves, better compliance to medical management of persistence of patent fistula at autopsy study.[26],[32],[33] It was suggested that patients with a shorter duration of symptoms had better responses after ONSF.[34] Headache improved in 66.67% of patients in our study, which was better than previously reported studies (41–50%).[30],[18] Remaining patients had a stable headache which did not worsen after surgery. As the fundus picture in these patients too improved after surgery, the persistence of headache suggests a nonspecific cause unrelated to IIH.

If the CSF diversion fails, there can be a rapid and severe deterioration in vision.[35] Kelman et al.[36] and Sergott et al.[37] demonstrated that in patients with functional CSF shunts with a persistent progressive visual deterioration which is suggestive of shunt failure, prophylactic ONSF may be beneficial. All the four patients who had an unsuccessful CSF diversion improved after ONSF.

Complication rates associated with the transconjunctival ONSF approach varies from 4.8–45%[38],[39] which included orbital hemorrhage, retinal artery occlusion, increased intraocular pressure, pupillary palsy, accommodation failure, and diplopia. Diplopia was found to be the most common complication in this approach.[7],[17]

Endoscopic procedures are associated with CSF leak, meningitis, subcutaneous orbital emphysema, epistaxis.[22] The inability to cut the falciform ligament[40] without risk of CSF leak forms another limitation of the endonasal approach. [Table 3]

The use of high-speed drills for decompression of bony optic canal in conventional transcranial ONSF has its share of operative risks.[11] Firstly, a rapidly rotating drill can tear and damage the nerve or lacerate the frontal lobe. Secondly, the rotating tip can cause contact injury to the optic apparatus and internal carotid artery. Thirdly, the heat generation due to the rotating drill can cause direct thermal injury to the nerve. The use of an ultrasonic bone aspirator, which works on the principle of to and fro movements and ultrasonic waves for bony decompression with inbuilt continuous irrigation poses limited risk of injury to adjacent structures. Further being extradural, a layer of subarachnoid CSF acts as a water bath cushion avoiding direct compression of the nerve.

The degree of optic nerve decompression achieved in our study was 270 degrees. Bony optic nerve decompression in earlier studies with transcranial than endonasal technique were 245.2 degrees and 114.8 degrees, respectively. The maximum degree of 180 of optic nerve decompression was achieved in the endoscopic endonasal approach in a review by Tarrats et al.[19] [Table 4] The dural incision on the basifrontal optic nerve is devoid of any major vessel, especially the ophthalmic artery which is encountered consistently in both endonasal endoscopic and transconjunctival route.
Table 4: Degree of optic canal decompression achieved in previous studies

Click here to view


The other major surgical procedure in current practice is the CSF diversion procedure. Initially, a VP shunt was used, however, had a limitation of tapping the small ventricles. Lumboperitoneal shunting for IIH was first described by Vander Ark et al. in 1971.[44] Spetzler developed a percutaneous technique for lumbar peritoneal (LP) shunt placement. An LP shunt works by draining the CSF and thus reducing the overall decrease in ICP and improvement in visual symptoms. Shunt surgeries though were effective in reducing the persistent headaches were found wanting in overall visual improvement as compared to ONSF. Feldon observed 47%, 44.6%, and 80% visual improvement following VP shunt, LP shunt, and ONSD, respectively.[28] The complications of ONSF are mainly related to the trajectory and injury to adjacent neurovascular structures. The trajectory which we have chosen is devoid of major vessels and nerves and hence is not comparable. The trans-conjunctival route has all whole orbit at risk while the endoscopic procedure has a major risk of injuring the carotids or inferiorly located ophthalmic artery. However, the majority of complications of ONSF were temporary. We had four patients with no improvement following LP shunt, who required ONSF. Subdural hygroma was another complication seen in our patient. The reported revision rates for LP shunts range from 38–64% (overall 52%). The number of revisions per patient has been reported as high as 6.6% (mean 3.9%). Low-pressure headaches, shunt dependency, sudden visual loss due to shunt block, infections, lumbar radiculopathy, CSF leaks, and acquired cerebellar tonsillar herniation are few other complications reported in the literature.[1]

Both ONSF and LP/VP shunt have their pros and cons and the debate on the topic has been inconclusive in the absence of head-on randomized control trials. The Cochrane review in 2005 “Interventions for idiopathic intracranial hypertension” was guarded in its recommendations of one surgical procedure over others. It, however, favored a surgical procedure over medical management in the event of visual loss.[13] We need to wait for the results of the ongoing SIGHT (Surgical idiopathic intracranial hypertension treatment) trial.

In nutshell, the advantages are as follows: 1) extradural, 2) CSF cushion around the optic nerve till the clionectomy, 3) lack of thermal injury by ultrasonic aspirator as compared to high-speed drill, 4) lack of mechanical entanglement of adjacent structures (high-speed drill), 5) maximal bony decompression (270 degrees), and 6) avoids potential infected space (trans-nasal, endoscopic approach).


 » Conclusion Top


Transcranial optic nerve sheath decompression with a bone ultrasonic aspirator is a safe and direct decompression of the optic nerve in malignant/refractory cases of IIH.

Declaration

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient (s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
 » References Top

1.
Friedman DI, Jacobson DM. Idiopathic intracranial hypertension. J Neuroophthalmol 2004;24:138-45.  Back to cited text no. 1
    
2.
Raoof N, Sharrack B, Pepper IM, Hickman SJ. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol 2011;18:1266-8.  Back to cited text no. 2
    
3.
Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: Mechanisms, management, and future directions. Lancet Neurol 2016;15:78-91.  Back to cited text no. 3
    
4.
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002;59:1492-5.  Back to cited text no. 4
    
5.
Thambisetty M, Lavin PJ, Newmand NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 2007;68:229-32.  Back to cited text no. 5
    
6.
Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clin Proc 1994;69:169-80.  Back to cited text no. 6
    
7.
Chandrasekaran S, McCluskey P, Minassian D, Assaad N. Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions. Clin Exp Ophthalmol 2006;34:661-5.  Back to cited text no. 7
    
8.
Gogela SL, Zimmer LA, Keller JT, Andaluz N. Refining operative strategies for optic nerve decompression: A morphometric analysis of transcranial and endoscopic endonasal techniques using clinical parameters. Oper Neurosurg (Hagerstown) 2017;14:295-302.  Back to cited text no. 8
    
9.
Karabatsou K, Quigley G, Buxton N, Foy P, Mallucci C. Lumboperitoneal shunts: Are the complications acceptable? Acta Neurochir (Wien) 2004;146:1193-7.  Back to cited text no. 9
    
10.
Son HE, Park MS, Kim SM, Jung SS, Park KS, Chung SY. The avoidance of microsurgical complications in the extradural anterior clinoidectomy to paraclinoid aneurysms. J Korean Neurosurg Soc 2010;48:199.  Back to cited text no. 10
    
11.
Chang HS, Joko M, Song JS, Ito K, Inoue T, Nakagawa H. Ultrasonic bone curettage for optic canal unroofing and anterior clinoidectomy. J Neurosurg 2006;104:621-4.  Back to cited text no. 11
    
12.
Binder DK, Horton JC, Lawton MT, McDermott MW. Idiopathic intracranial hypertension. Neurosurgery 2004;54:538-52.  Back to cited text no. 12
    
13.
Lueck C, McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2005:CD003434.  Back to cited text no. 13
    
14.
Frisén L. Swelling of the optic nerve head: A staging scheme. J Neurol Neurosurg Psychiatry 1982;45:13-8.  Back to cited text no. 14
    
15.
Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, et al. Visual loss in pseudotumor cerebri: Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982;39:461-74.  Back to cited text no. 15
    
16.
Spoor TC, McHenry JG. Long-term effectiveness of optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1993;111:632-5.  Back to cited text no. 16
    
17.
Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology 2000;107:1907-12.  Back to cited text no. 17
    
18.
Kalyvas AV, Hughes M, Koutsarnakis C, Moris D, Liakos F, Sakas DE, et al. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: A systematic review of the literature. Acta Neurochir (Wien) 2017;159:33-49.  Back to cited text no. 18
    
19.
Tarrats L, Hernández G, Busquets JM, Portela JC, Serrano LA, González-Sepúlveda L, et al. Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension. Int Forum Allergy Rhinol 2017;7:615-23.  Back to cited text no. 19
    
20.
Yu B, Chen Y, Ma Y, Tu Y, Wu W. Outcome of endoscopic trans-ethmosphenoid optic canal decompression for indirect traumatic optic neuropathy in children. BMC Ophthalmol 2018;18:152.  Back to cited text no. 20
    
21.
Yu B, Ma Y, Tu Y, Wu W. The outcome of endoscopic transethmosphenoid optic canal decompression for indirect traumatic optic neuropathy with no-light-perception. J Ophthalmol 2016;2016:6492858.  Back to cited text no. 21
    
22.
Berhouma M, Jacquesson T, Abouaf L, Vighetto A, Jouanneau E. Endoscopic endonasal optic nerve and orbital apex decompression for nontraumatic optic neuropathy: Surgical nuances and review of the literature. Neurosurg Focus 2014;37:E19.  Back to cited text no. 22
    
23.
De Wecker L. An incision of the optic nerve in cases of neuroretinitis. Int Ophthalmol Congress 1872;4:11-14.  Back to cited text no. 23
    
24.
Hayreh SS. Pathogenesis of oedema of the optic disc (papilloedema): a preliminary report. Br J Ophthalmol 1964;48:522-43.  Back to cited text no. 24
    
25.
Davidson SI. A surgical approach to plerocephalic disc oedema. Trans Ophthalmol Soc U K 1970;89:669-90.  Back to cited text no. 25
    
26.
Keltner JL. Optic nerve sheath decompression: How does it work? Has its time come? Arch Ophthalmol 1988;106:1365-9.  Back to cited text no. 26
    
27.
Burde RM, Karp JS, Miller RN. Letter: Reversal of visual deficit with optic nerve decompression in long-standing pseudotumor cerebri. Am J Ophthalmol 1974;77:770-2.  Back to cited text no. 27
    
28.
Feldon SE. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus 2007;23:E6.  Back to cited text no. 28
    
29.
Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri). Curr Neurol Neurosci Rep 2008;8:87-93.  Back to cited text no. 29
    
30.
Brazis PW. Clinical review: The surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 2008;28:1361-73.  Back to cited text no. 30
    
31.
Vaidya NS, Mahmoud AM, Buzzacco D, Katz SE. Visual outcomes following optic nerve sheath fenestration via the medial transconjunctival approach. Orbit 2016;35:271-7.  Back to cited text no. 31
    
32.
Alsuhaibani AH, Carter KD, Nerad JA, Lee AG. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology 2011;118:412-4.  Back to cited text no. 32
    
33.
Keltner JL, Albert DM, Lubow M, Fritsch E, Davey LM. Optic nerve decompression. A clinical pathologic study. Arch Ophthalmol 1977;95:97-104.  Back to cited text no. 33
    
34.
Pineles SL, Volpe NJ. Long-term results of optic nerve sheath fenestration for idiopathic intracranial hypertension: Earlier intervention favours improved outcomes. Neuroophthalmology 2013;37:12-9.  Back to cited text no. 34
    
35.
Liu GT, Volpe NJ, Schatz NJ, Galetta SL, Farrar JT, Raps EC. Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure. Am J Ophthalmol 1996;122:129-31.  Back to cited text no. 35
    
36.
Kelman SE, Sergott RC, Cioffi GA, Savino PJ, Bosley TM, Elman MJ. Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss. Ophthalmology 1991;98:1449-53.  Back to cited text no. 36
    
37.
Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988;106:1384-90.  Back to cited text no. 37
    
38.
Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology 1993;100:683-90.  Back to cited text no. 38
    
39.
Gilbert AL, Chwalisz B, Mallery R. Complications of optic nerve sheath fenestration as a treatment for idiopathic intracranial hypertension. Semin Ophthalmol 2018;33:36-41.  Back to cited text no. 39
    
40.
Srivastava AK, Singh S, Khatri D, Jaiswal AK, Sankar R, Paliwal VK, et al. Endoscopic endonasal optic nerve decompression with durotomy: Pis aller in the mind of a blind. Neurol India 2020;68:54-60.  Back to cited text no. 40
[PUBMED]  [Full text]  
41.
Patrocínio JA, Patrocínio LG, Júnior FB, da Cunha AR. Endoscopic decompression of the optic nerve in pseudotumor cerebri. Auris Nasus Larynx 2005;32:199-203.  Back to cited text no. 41
    
42.
Koc K, Anik I, Altintas O, Ceylan SA. Endoscopic optic nerve decompression for idiopathic intracranial hypertension in two cases: Case report. Minim Invasive Neurosurg 2008;51:72-5.  Back to cited text no. 42
    
43.
Yildirim AE, Karaoglu D, Divanlioglu D, Secen AE, Gurcay AG, Cagil E, et al. Endoscopic endonasal optic nerve decompression in a patient with pseudotumor cerebri. J Craniofac Surg 2015;26:240-2.  Back to cited text no. 43
    
44.
Vander Ark GD, Kempe LG, Smith DR. Pseudotumor cerebri treated with Lumbar-peritoneal shunt. JAMA 1971;217:1832-4.  Back to cited text no. 44
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]
 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4]



 

Top
Print this article  Email this article
   
Online since 20th March '04
Published by Wolters Kluwer - Medknow